Benztropine, sold under the brand name Cogentin, is an anticholinergic medication prescribed mainly to manage movement-related side effects of antipsychotic drugs and, less often, to treat Parkinson’s disease symptoms. Its side effects stem from blocking a chemical messenger called acetylcholine throughout the body, which means the drug affects far more than just movement. The result is a profile of side effects that ranges from merely annoying dry mouth to genuinely concerning effects on memory and mental clarity, and the picture gets more complicated with age, dose, and the number of other medications a person takes.
The Most Common Physical Side Effects
Because acetylcholine is involved in everything from saliva production to gut movement to bladder function, blocking it produces a predictable cluster of physical symptoms. Dry mouth is probably the most frequently reported complaint. In one head-to-head comparison, benztropine at a standard dose of 4 mg per day decreased measured saliva flow significantly more than amantadine, an alternative sometimes used for similar purposes.1PubMed. Anticholinergic effects on memory: benztropine versus amantadine Blurred vision is another frequent problem, caused by the drug’s effect on the muscles that focus the lens of the eye.
Beyond the mouth and eyes, benztropine commonly causes constipation and urinary retention. These are not trivial inconveniences. Severe constipation left untreated can progress to bowel obstruction, and urinary retention can lead to infection or, in extreme cases, bladder damage. A review of chronic anticholinergic prescribing in people with schizophrenia flagged both severe constipation and urinary retention as serious sequelae of ongoing use.2APA Publishing / Focus. Why Not Rock the Boat? Deprescribing Anticholinergic Medications That Are No Longer Needed in Persons With Schizophrenia Other commonly noted effects include drowsiness, dizziness, and sometimes a flushed feeling or reduced sweating, which can raise the risk of overheating in warm environments.
The good news is that many of these milder problems respond to dose changes. In a trial that used benztropine to reduce drooling in patients with neurological conditions, minor issues like dry mouth were eliminated by small dose adjustments. However, three patients developed more serious anticholinergic reactions that required stopping the drug entirely, though those effects resolved within 24 to 48 hours after discontinuation.3PubMed. Efficacy of benztropine therapy for drooling
Effects on Memory and Thinking
This is where benztropine’s side-effect profile moves from annoying to genuinely worrying for many patients. Acetylcholine plays a central role in forming new memories, and blocking it can interfere with that process in measurable ways. A controlled comparison found that benztropine at 4 mg per day impaired free recall and distorted perception of time, while amantadine at its typical dose did not.4PubMed. Anticholinergic effects on memory: benztropine versus amantadine Importantly, the people taking benztropine in that study noticed the memory problems themselves, rating their own memory as worse while on the drug.
The pattern of impairment is specific. Benztropine interferes mainly with the ability to store new information into long-term memory. Tasks that rely on immediate recall or on retrieving information already stored tend to be less affected. In practical terms, this means you might follow a conversation just fine in the moment but struggle to remember it later, or find it harder to learn new routines at work.
When benztropine is used for weeks or months rather than days, cognitive effects become a bigger concern. A clinical review noted that chronic prescribing of anticholinergic medications like benztropine carries the risk of ongoing cognitive impairment and, in more severe cases, delirium, a state of acute confusion that can be frightening and dangerous.5APA Publishing / Focus. Why Not Rock the Boat? Deprescribing Anticholinergic Medications That Are No Longer Needed in Persons With Schizophrenia This has led many psychiatrists to recommend periodically re-evaluating whether a patient still needs the drug, rather than leaving it on the medication list indefinitely.
When Multiple Medications Compound the Problem
Benztropine is rarely the only medication a person takes. It is most often prescribed alongside antipsychotic drugs, and many people on antipsychotics also take antidepressants, sleep aids, or medications for other conditions. The catch is that many of those other medications also have some degree of anticholinergic activity. A first-generation antihistamine for allergies, certain bladder medications, older antidepressants, and even some over-the-counter sleep aids all block acetylcholine to varying degrees.
The effects are cumulative. Each additional medication with anticholinergic properties adds to the total “anticholinergic burden” on the body, and the combined effect can push side effects from tolerable into dangerous territory. A review of anticholinergic safety noted that symptoms can range from subtle cognitive impairment to outright delirium, depending on how much total anticholinergic activity a person’s medication list adds up to.6Expert Opinion on Drug Safety. Drugs with anticholinergic properties: a current perspective on use and safety The risk compounds further when benztropine is prescribed alongside other anticholinergic medications, as each one amplifies the associated side effects.7APA Publishing / Focus. Why Not Rock the Boat? Deprescribing Anticholinergic Medications That Are No Longer Needed in Persons With Schizophrenia
This is one reason why a pharmacist or prescriber reviewing your full medication list matters so much. You might tolerate benztropine well on its own but develop confusion or severe constipation after adding an unrelated medication that happens to have anticholinergic properties. If you take benztropine and are prescribed something new, it is worth asking specifically whether the new drug adds to anticholinergic load.
Eye-Related Risks
Blurred vision from benztropine is common and usually not dangerous on its own. The more serious concern involves the drug’s effect on pupil dilation. Anticholinergic medications cause the pupils to widen, which in most people is harmless. But in someone with narrow drainage angles in the eye, a condition they may not even know they have, pupil dilation can trigger a sudden spike in eye pressure known as acute angle-closure glaucoma. This is a medical emergency that can cause permanent vision loss if not treated quickly.8Annals of Emergency Medicine. The pathophysiology of glaucoma is reviewed, and the risks of pharmacologic pupillary dilation are discussed
The risk is low in the general population, but it is not zero. People with a family history of glaucoma, those of East Asian descent (who have higher rates of narrow angles), and older adults are at greater risk. If you experience sudden eye pain, halos around lights, or a rapid change in vision after starting benztropine, that warrants an urgent evaluation.
What Happens in Overdose
Benztropine overdose produces a severe version of the same anticholinergic effects seen at therapeutic doses, sometimes described by the mnemonic “hot as a hare, blind as a bat, dry as a bone, red as a beet, mad as a hatter.” In plain terms, this means dangerously high body temperature, widely dilated pupils, completely dry skin and mucous membranes, flushed skin, and delirium or hallucinations.
What makes benztropine overdose particularly tricky is how long it can last. In one documented case, a 38-year-old man who overdosed on benztropine developed anticholinergic poisoning that persisted for nine days. Blood levels of the drug fluctuated during his hospitalization, suggesting that the lengthy intoxication was caused by prolonged, intermittent absorption from the gut rather than the body being slow to clear the drug from the bloodstream.9The American Journal of Emergency Medicine. Serial serum drug concentrations and prolonged anticholinergic toxicity after benztropine (Cogentin) overdose This matters because it means emergency physicians cannot assume that once blood levels start dropping, the patient is out of danger. The drug sitting in the gut can continue to be absorbed in waves.
In a hospital setting, anticholinergic overdose is treated supportively with cooling measures, IV fluids, and sometimes physostigmine, a drug that temporarily reverses acetylcholine blockade. The nine-day case is a reminder that observation periods after benztropine overdose may need to be longer than for many other medications.
Older Adults Face Higher Risks
Aging changes the equation for benztropine in several ways. Older adults tend to be more sensitive to anticholinergic effects at baseline, partly because acetylcholine activity in the brain naturally declines with age. Adding a drug that further reduces it can tip someone from normal cognition into confusion or delirium more easily than it would in a younger person. Benztropine appears on the Beers Criteria, a widely used list of medications considered potentially inappropriate for older adults, specifically because of the cognitive and fall-related risks in this population.
The cumulative burden issue described earlier is also more pronounced in older adults, who are statistically more likely to take multiple medications. An older person on benztropine plus a bladder medication plus a nighttime antihistamine might be getting three times the anticholinergic exposure that any one of those drugs would deliver alone. The practical consequence is not just foggier thinking but also a higher risk of falls, which in older adults can cascade into fractures, hospitalization, and loss of independence.
There is also growing concern, though the evidence is still being worked out, about whether long-term anticholinergic use contributes to a higher risk of dementia over time. This research is not specific to benztropine alone but applies to the broader class of anticholinergic drugs. For older adults, the question of whether benztropine is still necessary becomes especially important to revisit regularly with a prescriber.
Use in Children
Benztropine is sometimes used in children, most often to manage drooling (sialorrhea) in those with neurological conditions such as cerebral palsy. A systematic review of anticholinergic treatments for drooling in children found that benztropine, along with several other anticholinergics, showed evidence of being effective. However, adverse side effects were common across all the anticholinergic drugs studied.10Paediatrics & Child Health. Anticholinergic treatment for sialorrhea in children: A systematic review
Children face the same types of side effects as adults, including dry mouth, constipation, and blurred vision, but they may be less able to articulate what they are feeling. A child who becomes irritable, stops eating well, or seems unusually flushed may be experiencing anticholinergic side effects without being able to describe them. The drooling trial mentioned earlier found that more serious side effects in some patients required stopping the drug, though the effects resolved within a couple of days.11PubMed. Efficacy of benztropine therapy for drooling For children, careful dose titration and close monitoring are particularly important, since smaller bodies leave less margin for error.
How Side Effects Influence Whether People Stay on the Drug
Side effects are not just a medical concern. They are a practical barrier to treatment. Benztropine is typically prescribed to counteract movement problems caused by antipsychotic medications, so a person who stops benztropine because of intolerable side effects may then face a return of those movement problems. This creates a frustrating tradeoff: the drug that fixes one set of symptoms introduces a new set.
A review of neurological side effects from psychotropic medications noted that when side effects are not managed promptly, they become a significant factor driving poor medication compliance and tolerability, ultimately undermining the efficacy of the overall treatment plan.12Psychiatric Annals. Neurological Side Effects of Psychotropic Medications In real terms, this means someone might stop not just benztropine but their antipsychotic as well, because the whole medication regimen feels unbearable.
This is why clinicians increasingly advocate for periodic “deprescribing” attempts, tapering benztropine to see whether the movement side effects it was originally prescribed for have resolved on their own (as they sometimes do after a person has been on a stable antipsychotic dose for a while). If the movement problems do not return, the person can stay off benztropine and avoid its side effects entirely. If they do come back, alternatives with milder anticholinergic profiles can sometimes be tried. The study comparing benztropine with amantadine, for instance, found that amantadine caused fewer anticholinergic effects and less memory impairment, making it a potential substitute for some patients.13PubMed. Anticholinergic effects on memory: benztropine versus amantadine
The Abuse and Dependence Question
Benztropine has a mixed reputation when it comes to misuse. It does interact with the dopamine transporter, the same molecular target that cocaine and other stimulants bind to, which has raised questions about its abuse potential. Research into how benztropine binds to this transporter has found something interesting: although the drug does block dopamine reuptake in a technical sense, it does not produce the rush of euphoria or the reinforcing effects that characterize addictive stimulants.14Neurochemistry International. Identification of the benztropine analog [(125)I]GA II 34 binding site on the human dopamine transporter Researchers believe this is because benztropine stabilizes the transporter in a different shape than cocaine does, which changes what happens downstream in the brain’s reward circuits.
That said, reports of benztropine misuse do exist in clinical practice, particularly in institutional or forensic psychiatric settings. Some people take higher-than-prescribed doses seeking a mild “buzz” or feelings of relaxation, and others combine it with other substances. The drug is not a controlled substance in most jurisdictions, but prescribers in certain settings treat it with caution and may prefer alternatives that have even less misuse potential.
Heat Intolerance and Reduced Sweating
One side effect that deserves more attention than it usually gets is benztropine’s impact on sweating. Acetylcholine stimulates the sweat glands, and blocking it can significantly reduce your ability to sweat. This might sound like a minor issue, but sweating is the body’s primary cooling mechanism. During hot weather or vigorous activity, someone on benztropine can overheat much more quickly than they would otherwise.
This is particularly relevant for people taking antipsychotic medications alongside benztropine, because some antipsychotics can independently affect the body’s temperature regulation. The combination raises the risk of heat-related illness, from heat exhaustion to potentially life-threatening heat stroke. If you take benztropine, staying well hydrated and avoiding prolonged heat exposure during summer months is not just sensible advice but a genuine safety precaution. Caregivers of children or older adults on benztropine should be especially watchful during heat waves, since both groups are already more vulnerable to heat illness.